9 completed, 4 recruiting, 2 unknown, 1 active not recruiting. 5 Not applicable, 4 Phase 3, 3 Phase 2, 2 Phase 1, 2 Phase 4.
Follow Asthma, Allergic: new trials by email Literature Review of Asthma, Allergic trials Research Report on Asthma, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biologics and Sublingual Immunotherapy omalizumab - Asthma, Allergic | Phase 4 | Not yet recruiting | Medical University of Silesia | 150 | 2024-05-01 | 2023-09-07 |
| Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma Tezepelumab, Placebo - Asthma, Allergic | Phase 2 | Unknown | McMaster University | 34 | 2023-04-01 | 2023-02-23 |
| Dupilumab Effects Against Aeroallergen Challenge Dupilumab, House Dust Mites (HDM), Placebo - Asthma, Allergic | Phase 2 | Active not recruiting | The University of Texas Health Science Center at San Antonio | 96 | 2023-03-29 | 2026-08-11 |
| IL13 Signaling in Allergic Asthma Asthma, Allergic, Asthma | Completed | Duke University | 28 | 2023-02-21 | 2026-01-29 | |
| Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma. Biocide - Asthma, Allergic | Not applicable | Unknown | Puressentiel | 80 | 2022-05-01 | 2022-04-28 |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen 10,000 MG01 + 10,000 T517, 30,000 MG01 + 10,000 T517, Placebo - Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 180 | 2021-06-14 | 2025-05-07 |
| Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. 10,000 MG01 +10,000 T521, 30,000 MG01 +10,000 T521, Placebo subcutaneous - Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 180 | 2021-05-31 | 2025-05-13 |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites 10,000 MM09, 30,000 MM09, Placebo subcutaneous - Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 150 | 2020-10-06 | 2025-05-13 |
| Anakinra as a Rescue Treatment for Allergic Inflammation Anakinra, Preservative-free 0.9% sodium chloride (Placebo), House dust mite allergen - Asthma, Allergic | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-12-16 | 2022-06-08 | |
| Effects of Low Dose Ozone on Airway Inflammatory Responses in Adults With Asthma - Sedentary Nasal Ozone (Asthma SNOZ) Ozone, FA - Asthma, Allergic | Not applicable | Suspended | University of North Carolina, Chapel Hill | 18 | 2019-12-16 | 2025-12-17 |
| Lung-Resident Memory Th2 Cells in Asthma Bronchoscopy/BAL, Airway Brushing - Asthma, Allergic | Not applicable | Completed | Andrew D. Luster, M.D.,Ph.D. | 37 | 2019-05-23 | 2026-09-30 |
| Plant Stanol Esters and Preventing Asthma Symptoms Soft chews containing 0.5g plant stanols (delivered as plant stanol esters), Placebo soft chew - Asthma, Allergic, Cardiovascular Diseases | Not applicable | Recruiting | Maastricht University Medical Center | 160 | 2019-04-29 | 2026-06-25 |
| Evaluating Asthma Exacerbation-induced Changes in Lung Function With a Home-based Spirometer Spirobank Smart spirometer - Asthma, Asthma Attack | Not applicable | Completed | VitalFlo Inc. | 44 | 2019-02-22 | 2020-10-06 |
| Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. CMAB007, Symbicort, Seretide - Asthma, Allergic | Phase 3 | Completed | Shanghai Biomabs Pharmaceutical Co., Ltd. | 393 | 2018-05-09 | 2021-10-11 |
| Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children Rhinitis, Allergic, Asthma, Allergic | Completed | Second Affiliated Hospital, Zhejiang University, School of Medicine | 407 | 2018-01-01 | 2023-10-18 | |
| Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma Asthma Persistent, Asthma, Allergic | Completed | TC Erciyes University | 95 | 2017-11-27 | 2019-07-18 | |
| Study of REGN3500 and Dupilumab in Patients With Asthma REGN3500, Dupilumab, Placebo - Asthma, Allergic | Phase 1 | Completed | Regeneron Pharmaceuticals | 32 | 2017-06-15 | 2020-01-18 |
| Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis Azelastine-Fluticasone Nasal, Placebos - Asthma, Allergic, Rhinitis,Allergic | Phase 4 | Terminated | University of Dundee | 7 | 2017-01-20 | 2019-04-08 |
| ICS Treatment Compliance of Asthma Patients No Intervention - Asthma, Allergic | Completed | First Affiliated Hospital Xi'an Jiaotong University | 350 | 2016-11-01 | 2019-08-14 | |
| Validation of Proteomic Analyses for Allergic Asthma and Rhinitis Classification as "asthmatic" or "rhinitis only" via proteomic analysis, Classification as "asthmatic" or "rhinitis only" according to a metacholine test - Rhinitis, Allergic, Asthma, Allergic | Completed | Centre Hospitalier Universitaire de Nīmes | 133 | 2010-05-01 | 2015-03-27 |
Asthma (20) · Rhinitis, Allergic (6) · Hypersensitivity (4) · Cardiovascular Diseases (1) · Chronic Urticaria (1) · Conjunctivitis, Allergic (1) · Dermatitis, Atopic (1) · Disease (1) · Dust Mite Allergy (1) · Eosinophilia (1) · Inflammation (1) · Obesity (1) · Pulmonary Eosinophilia (1) · Respiratory Hypersensitivity (1) · Rhinitis (1)
Bronchial Diseases (20) · Hypersensitivity, Immediate (20) · Immune System Diseases (20) · Lung Diseases (20) · Lung Diseases, Obstructive (20) · Respiratory Tract Diseases (20) · Respiratory Hypersensitivity (19) · Hypersensitivity (16) · Nose Diseases (7) · Otorhinolaryngologic Diseases (7) · Rhinitis (6) · Pathological Conditions, Signs and Symptoms (4) · Pathologic Processes (3) · Body Weight (1) · Chronic Disease (1)
Antigens, Dermatophagoides (2) · dupilumab (2) · Albuterol (1) · Budesonide (1) · Budesonide, Formoterol Fumarate Drug Combination (1) · Disinfectants (1) · Fluticasone (1) · Fluticasone-Salmeterol Drug Combination (1) · Inhalation (1) · Interleukin 1 Receptor Antagonist Protein (1) · Omalizumab (1) · Ozone (1) · Parturition (1) · Sodium Chloride (1) · itepekimab (1)
Inmunotek S.L. (3) · University of North Carolina, Chapel Hill (2) · Andrew D. Luster, M.D.,Ph.D. (1) · Centre Hospitalier Universitaire de Nīmes (1) · Duke University (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Maastricht University Medical Center (1) · McMaster University (1) · Medical University of Silesia (1) · Puressentiel (1) · Regeneron Pharmaceuticals (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Shanghai Biomabs Pharmaceutical Co., Ltd. (1) · TC Erciyes University (1) · The University of Texas Health Science Center at San Antonio (1)
United States (6) · Spain (3) · China (2) · United Kingdom (2) · Canada (1) · France (1) · Netherlands (1) · Turkey (Türkiye) (1)
Allison Burbank, MD (1) · Andrew D Luster (1) · Brian Lipworth, MD (1) · David Peden, MD (1) · Francisco Moreno, MD (1) · Gail Gauvreau, PhD (1) · Huiying Wang (1) · Jogchum Plat, PhD (1) · Loretta Que, MD (1) · Manxiang Li, PhD (1) · Michelle Hernandez (1) · Nanshan Zhong, M.D. (1) · Nicolas Molinari, PhD (1)
PMID 39363801, PMID 41345745, PMID 41519381
2015 (1), 2016 (1), 2018 (1), R01AI040618 (1), R01HL135235 (1), U01AI158460 (1)